Literature DB >> 3937130

[Comparative activity of minocycline and doxycycline on mycoplasmas pathogenic for man].

C Bebear, P Cantet, H Renaudin, C Quentin.   

Abstract

Susceptibility of Mycoplasma pneumoniae (10 strains), Mycoplasma hominis (20 strains) and Ureaplasma urealyticum (100 strains) to minocycline and doxycycline was studied in vitro. Minimal inhibitory concentrations were determined using an agar dilution method for M. pneumoniae and M. hominis and a metabolic inhibition test for U. urealyticum. M. pneumoniae strains were highly susceptible to minocycline and doxycycline (MIC less than or equal to 0.1 mg/l). Among M. hominis strains, 17 were susceptible (MIC less than or equal to 0.1 mg/l), whereas 3 were inhibited only by concentrations ranging from 4 to 16 mg/l. Among the 100 U. urealyticum strains, 95 were inhibited by 4 mg/l minocycline and 94 by 4 mg/l doxycycline. Both antibiotics exhibited similar activities against the three species (same ranges, same mode MICs).

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3937130

Source DB:  PubMed          Journal:  Pathol Biol (Paris)        ISSN: 0369-8114


  8 in total

1.  In vitro susceptibilities of Mycoplasma genitalium to antibiotics.

Authors:  H Renaudin; J G Tully; C Bebear
Journal:  Antimicrob Agents Chemother       Date:  1992-04       Impact factor: 5.191

2.  In vitro activity of BAY 12-8039, a new fluoroquinolone against mycoplasmas.

Authors:  C M Bébéar; H Renaudin; A Boudjadja; C Bébéar
Journal:  Antimicrob Agents Chemother       Date:  1998-03       Impact factor: 5.191

3.  In vitro susceptibility of mycoplasmas to a new quinolone, BAY Y 3118.

Authors:  H Renaudin; C Bébéar
Journal:  Drugs       Date:  1995       Impact factor: 9.546

4.  Characterization of Mycoplasma hominis mutations involved in resistance to fluoroquinolones.

Authors:  C M Bebear; J M Bové; C Bebear; J Renaudin
Journal:  Antimicrob Agents Chemother       Date:  1997-02       Impact factor: 5.191

5.  Comparison of methods for in vitro testing of susceptibility of porcine Mycoplasma species to antimicrobial agents.

Authors:  E A Ter Laak; A Pijpers; J H Noordergraaf; E C Schoevers; J H Verheijden
Journal:  Antimicrob Agents Chemother       Date:  1991-02       Impact factor: 5.191

6.  Susceptibilities of Mycoplasma hominis, Mycoplasma pneumoniae, and Ureaplasma urealyticum to new glycylcyclines in comparison with those to older tetracyclines.

Authors:  G E Kenny; F D Cartwright
Journal:  Antimicrob Agents Chemother       Date:  1994-11       Impact factor: 5.191

7.  Comparative in vitro activity of azithromycin, clarithromycin, erythromycin and lomefloxacin against Mycoplasma pneumoniae, Mycoplasma hominis and Ureaplasma urealyticum.

Authors:  H Renaudin; C Bébéar
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1990-11       Impact factor: 3.267

8.  Airway epithelial NF-κB activation promotes Mycoplasma pneumoniae clearance in mice.

Authors:  Di Jiang; Mark L Nelson; Fabienne Gally; Sean Smith; Qun Wu; Maisha Minor; Stephanie Case; Jyoti Thaikoottathil; Hong Wei Chu
Journal:  PLoS One       Date:  2012-12-28       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.